Activin A and TGF-β stimulate phosphorylation of focal adhesion proteins and cytoskeletal reorganization in rat aortic smooth muscle cells

Experimental Cell Research

Volumn 251, Issue 1, 1999, Pages 194-202

  Riedy, M C ^a   Brown, Michael C ^a   Molloy, Christopher J ^b   Turner, Christopher E ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

Cytoskeleton; FAK; Migration; p130(cas); Paxillin

Indexed keywords

ACTIN; ACTIVIN A; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; PHOSPHOTYROSINE; PROTEIN SERINE THREONINE KINASE; RECEPTOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CYTOSKELETON; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; TISSUE REPAIR;

EID: 0033603816     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4573     Document Type: Article

References (45)

1. Gibbon G. H., Dzau V. J. Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension. Cardiovasc. Drugs Therapy. 4:1990;237-242.
2. Pawlowski J. E., Taylor D. S., Valentine M., Hail M. E., Ferrer P., Kowala M. C., Molloy C. J. Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo. J. Clin. Invest. 100:1997;639-648.
3. Murphy T. J., Alexander R. W., Griendling K. K., Runge M. S., Bernstein K. E. Isolation of a cDNA encoding the vascular type I angiotensin II receptor. Nature. 351:1991;233-236.
4. Sasaki K., Yamano Y., Bardhan S., Iwai N., Murray J. J., Hasegawa M., Matsuda Y., Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 351:1991;230-233.
5. Sandberg K., Ji H., Clark A. J. L., Shapira H., Catt K. J. Cloning and expression of a novel angiotensin II receptor subtype. J. Biol. Chem. 267:1992;9455-9458.
6. Massague J., Hata A., Liu F. TGF-β signalling through the SMAD pathway. Trends Cell Biol. 7:1997;187-192.
7. Massague J. TGFβ signalling: Receptors, transducers and MAD proteins. Cell. 85:1996;947-950.
8. Derynck R., Zhang Y. Intracellular signaling: The MAD way to do it. Curr. Biol. 6:1996;1226-1229.
9. Wrana J. L., Attisano L. MAD-related proteins in TGF-β signalling. Trends Genet. 12:1996;493-496.
10. Zhang Y., Feng X-H., Wu R-Y., Derynck R. Receptor-associated MAD homologues synergize as effectors of the TGFβ response. Nature. 383:1996;168-172.
11. Ling N., Ying S. Y., Ueno N., Shimasaki S., Esch F., Hotta M., Guillemin R. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature. 321:1986;779-782.
12. Vale W., Rivier J., Vaughan J., McClintock R., Corrigan A., Woo W., Darr D., Spiess J. Purification and characterization of a FSH releasing protein from porcine ovarian follicular fluid. Nature. 321:1986;776-779.
13. Matthews L. S., Vale W. W. Molecular and functional characterization of activin receptors. Receptor. 3:1993;173-181.
14. Kojima I., Mogami H., Kawamura M., Yasuda H., Shibata H. Modulation of vascular smooth muscle cells by activin-A. Exp. Cell. Res. 206:1993;152-156.
15. Nishihara T., Okahashi N., Ueda N. Activin A induces apoptotic cell death. Biochem. Biophys. Res. Commun. 197:1993;985-991.
16. Mii S., Ware J. A., Kent K. C. Transforming growth factor-beta inhibits human vascular smooth muscle cell growth and migration. Surgery. 114:1993;464-470.
17. Frey R. S., Mulder K. M. Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/jun N-terminal kinase activation by transforming growth factor β in the negative growth control of breast cancer cells. Cancer Res. 57:1997;628-633.
18. Hartsough M. T., Frey R. S., Zipfel P. A., Buard A., Cook S. J., McCormick F. M., Mulder K. M. Altered transforming growth factor β signaling in epithelial cells when Ras activation is blocked. J. Biol. Chem. 271:1996;22368-22375.
19. Turner C. E., Pietras K. M., Taylor D. S., Molloy C. J. Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J. Cell Sci. 108:1995;333-342.
20. Cas to focal adhesions. Mol. Cell. Biol. 17:1997;3884-3897.
21. Klemeke R. L., Leng J., Molaner R., Brooks P. C., Vuori K., Cheresh D. A. CAS/CRK coupling serves as a "molecular switch" for induction of cell migration. J. Cell Biol. 140:1998;961-972.
22. Cas as a mediator of focal adhesion kinase-promoted cell migration. J. Cell Biol. 140:1998;211-221.
23. Huttenlocher A., Ginsberg M., Horwitz A. Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J. Cell Biol. 134:1996;1551-1562.
24. Kono S., Kuzuya H., Yamada K., Yoshimsa Y., Okamoto M., Inoue G., Hayashi T., Suga J., Imura H., Nakao K. A novel substrate for insulin-sensitive serine/threonine kinase in intact cells. Endocrinology. 135:1994;1529-1536.
25. Bellis S. L., Perrotta J. A., Curtis M. S., Turner C. E. Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin. Biochem. J. 325:1997;375-381.
26. DeNichilo M. O., Yamada K. M. Integrin alpha V beta 5-dependent serine phosphorylation of paxillin in cultured human macrophages adherent to vitronectin. J. Biol. Chem. 271:1996;11016-11022.
27. Sadoshima J. I., Izumo S. The heterotrimeric Gq protein-coupled angiotensin II receptor activates p21ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J. 15:1996;775-787.
28. Li X., Earp H. S. Paxillin is tyrosine-phosphorylated by and preferentially associates with the calcium-dependent tyrosine kinase in rat liver epithelial cells. J. Biol. Chem. 272:1997;14341-14348.
29. Molloy C. J., Pawlowski J. E., Taylor D. S., Turner C. E., Weber H., Peluso M., Seiler S. M. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the Raf1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells. J. Clin. Invest. 97:1996;1173-1183.
30. Molloy C. J. Signal transduction targets involved in fibroproliferative vascular disorder. Curr. Pharm. Design. 3:1997;585-596.
31. Bornfeldt K., Raines E., Nakano T., Graves L., Krebs E., Ross R. Insulin-like growth factor and PDGF-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest. 93:1994;1266-1274.
32. Griendling K. K., Rittenhouse S. E., Brock T. A., Ekstein L. S., Gimbrone M. A., Alexander R. W. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J. Biol. Chem. 261:1986;5901-5906.
33. Klemke R. L., Cai S., Giannini A. L., Gallagher P. J., de Lanerolle P., Cherish D. A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137:1997;481-492.
34. Hubner G., Hu Q., Smola H., Werner S. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev. Biol. 173:1996;490-498.
35. Plopper G. E., McNamee H. P., Dike L. E., Bojanowski K., Ingber D. E. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell. 6:1995;1349-1365.
36. Miyamoto S., Teramoto H., Gutkind J. S., Yamada K. M. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 135:1996;1633-1642.
37. Griendling K. K., Tsuda T., Berk B. C., Alexander R. W. Angiotensin II stimulation of vascular smooth muscle. J. Cardio. Pharm. 14:1989;S27-S33.
38. Molloy C. J., Taylor D. S., Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 268:1993;7338-7345.
39. Duff J. L., Marrero M. B., Paxton W. G., Schieffer B., Bernstein K. E., Berk B. C. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Cardiovascular Res. 30:1995;511-517.
40. Berk B. C., Corson M. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Cir. Res. 80:1997;607-616.
41. Brown M. C., Perrotta J. A., Turner C. E. Serine and threonine phosphorylation of the paxillin LIM domains regulates paxillin focal adhesion localization and cell adhesion to fibronection. Mol. Biol. Cell. 9:1998;1803-1816.
42. Graf K., Xi X-P., Yang D., Fleck E., Hsuch W. A., Law R. E. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 29:1997;334-339.
43. Schlaepfer D. D., Hunter T. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J. Biol. Chem. 272:1997;13189-13195.
44. Hocevar B. A., Brown T. L., Howe P. H. TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18:1999;1345-1356.
45. Maruyama I., Shigeta K., Miyahara H., Nakajima T., Shin H., Ide S., Kitajima I. Thrombin activates NF-kB through thrombin receptor and results in proliferation of vascular smooth muscle cells: Role of thrombin in atherosclerosis and restenosis. Ann. N.Y. Acad. Sci. 811:1997;429-436.